RecruitingNot ApplicableNCT05709210

Pilot Study on the Feasibility of Using Smartphone Data as a Diagnostic Marker for Alzheimer's Disease


Sponsor

Poitiers University Hospital

Enrollment

90 participants

Start Date

Jul 20, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

This study will compare smartphone usage data between three groups of patients diagnosed with either a memory complaint, mild cognitive decline, or Alzheimer's disease.


Eligibility

Min Age: 60 Years

Plain Language Summary

Simplified for easier understanding

This study is exploring whether data collected from a person's smartphone — such as how they type, move, and use their device — can be used as an early marker to help diagnose Alzheimer's disease. **You may be eligible if...** - You are a patient receiving routine care at a memory clinic - You have no sensory impairments that would prevent you from using a smartphone normally **You may NOT be eligible if...** - Your cognitive test score (MMSE) is below 20, or you cannot complete the test - You have another type of brain condition (such as Parkinson's disease, Lewy body disease, or ALS) - You have severe anxiety or depression - You have a serious illness in its final stages - You have a brain lesion on MRI that may be causing cognitive problems Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERRecording of smartphone usage data

Recording of smartphone usage data


Locations(1)

CHU Poitiers

Poitiers, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05709210


Related Trials